J Korean Med Sci.
2019 Mar;34(9):e82. 10.3346/jkms.2019.34.e82.
Erratum: Correction of Title: Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease
- KMID: 2441918
- DOI: http://doi.org/10.3346/jkms.2019.34.e82
Abstract
- In the initial published version of this article, there was a mistake in the title. The correct title should be "Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation on the Treatment Outcome of Non-Malignant Disease".
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease
- What should we consider in mixed chimerism after hematopoietic stem cell transplantation?
- Successful engraftment after infusion of multiple low doses of CD34+ cells from a poorly matched sibling donor in a patient with severe aplastic anemia
- Hematopoietic Stem Cell Transplantation Using Non-myeloablative Preparative Regimens
- Lineage-specific chimerism analysis in nucleated cells, T cells and natural killer cells after myeloablative allogeneic hematopoietic stem cell transplantation
